Grifols enters into agreement with Canadian Blood Services to accelerate self-sufficiency in immunoglobulins for Canada

7 September 2022 - The country, with an increasing immunoglobulin usage rate, currently imports about 85% of its immunoglobulin demand for ...

Read more →

Novo Nordisk expands product offerings in Canada for the treatment of haemophilia A in both children and adults, with availability of Esperoct and Zonovate

1 April 2022 - Newly available treatments can help Canadians living with haemophilia A better manage their bleeding episodes ...

Read more →

Campaign launched for life-sustaining treatment access across Canada

31 May 2021 - Alpha-1 Canada publicly launched Access for Alphas today, a campaign aimed at raising the awareness of alfa-1 ...

Read more →

Successful Eloctaq bid should widen access to the drug in the UK

29 June 2020 - The NHS and Sobi UK have come to an agreement that will give people living with ...

Read more →

Andexanet alfa for reversing anticoagulation

21 April 2020 - The Department of Health and Social Care has asked NICE to produce guidance on using andexanet alfa ...

Read more →

PHARMAC fully funding innovative improvements in haemophilia treatment

30 April 2019 - PHARMAC has today provided haemophilia patients fully funded access to new innovative treatment options which will ...

Read more →

Decision to make changes to funded haemophilia treatments

8 March 2019 - PHARMAC is pleased to announce changes to funded haemophilia treatments that will result in two new ...

Read more →

Proposal for changes to funded haemophilia treatments

29 January 2019 - PHARMAC is proposing to make changes to the funding of haemophilia treatments from 1 May 2019, ...

Read more →

Draft NICE decision rejects Respreeza for incurable, genetic disorder

27 September 2018 - NICE has published draft guidelines rejecting NHS use of CSL Behring’s Respreeza for treating emphysema in ...

Read more →

RFP - supply of recombinant factor VIII, recombinant factor IX and bypassing agents for the treatment of haemophilia

23 July 2018 - PHARMAC invites proposals for the supply of Recombinant Factor VIII, Recombinant Factor IX and bypassing agents (Recombinant ...

Read more →

Agenda for 31 January TC meeting

29 January 2018 - HAS has posted the agenda for the next scheduled TC meeting. ...

Read more →

Agenda for 13 December TC meeting

11 December 2017 - HAS has posted the agenda for the next scheduled TC meeting. ...

Read more →

Agenda for 22 November TC meeting

22 November 2017 - HAS has posted the agenda for the next scheduled TC meeting. ...

Read more →

Agenda for 25 October TC meeting

20 October 2017 - HAS has posted the agenda for the next scheduled TC meeting. ...

Read more →

Agenda for 19 October Transparency Commission meeting

12 October 2016 - HAS has published the agenda for the next scheduled Transparency Commission meeting. ...

Read more →